{"result": "(\"entity\"<|>N-10<|>ORGANIZATION<|>N-10 is a type of standard diet used in parenteral nutrition, providing specific nutritional components for patients.)\n##\n(\"entity\"<|>N-12<|>ORGANIZATION<|>N-12 is a type of standard diet used in parenteral nutrition, designed to meet the nutritional needs of patients.)\n##\n(\"entity\"<|>N-14<|>ORGANIZATION<|>N-14 is a type of standard diet used in parenteral nutrition, offering a specific balance of nutrients.)\n##\n(\"entity\"<|>N-16<|>ORGANIZATION<|>N-16 is a type of standard diet used in parenteral nutrition, formulated for particular patient requirements.)\n##\n(\"entity\"<|>N-11<|>ORGANIZATION<|>N-11 is a type of standard diet used in parenteral nutrition, tailored to provide essential nutrients.)\n##\n(\"entity\"<|>N-13<|>ORGANIZATION<|>N-13 is a type of standard diet used in parenteral nutrition, focusing on specific dietary needs.)\n##\n(\"entity\"<|>N-9 P<|>ORGANIZATION<|>N-9 P is a type of standard diet used in parenteral nutrition, designed for particular patient conditions.)\n##\n(\"entity\"<|>ISOPLASMAL<|>ORGANIZATION<|>Isoplasmal is a type of nutritional product used in parenteral nutrition, providing essential nutrients for patients.)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>N-10<|>N-10 is a standard diet used in parenteral nutrition to meet specific dietary needs<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>N-12<|>N-12 is a standard diet used in parenteral nutrition to provide essential nutrients<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>N-14<|>N-14 is a standard diet used in parenteral nutrition to support patient recovery<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>N-16<|>N-16 is a standard diet used in parenteral nutrition for specific patient requirements<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>N-11<|>N-11 is a standard diet used in parenteral nutrition to ensure adequate nutrient intake<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>N-13<|>N-13 is a standard diet used in parenteral nutrition to address particular dietary needs<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>N-9 P<|>N-9 P is a standard diet used in parenteral nutrition for specific patient conditions<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>ISOPLASMAL<|>Isoplasmal is a nutritional product used in parenteral nutrition to provide essential nutrients<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ---               20               25              22             29              34                23,8             ---                ---                ---                0,03                ---\n LCT (%)                           23,3                100                        80                       78             71              66                76,2            100                100                 100                 7,8                100\n Energía                           15,8%               43%              55%                              25%             25%                      40%                       30%                19%                34%                 45%                49%\n Ratio w6/w3                   no reportado          18,0:1             3,8:1            1,5:1           0,6:1          0,9:1                     1.5:1                    4,9:1                                  8,4:1              2,6:1               3,2:1\n Sodio (mg)                        123,6               184                       656                      535            350            237,5                95            1000                350                 205                700                 450\n Potasio (mg)                      330,4               264                       980                      670            450             640                 256           1500                275                 360                825                 670\n Vía de administración          Oral/Sonda         Oral/Sonda                Oral/Sonda                  Sonda           Oral           Sonda                Oral          Sonda               Oral                Oral           Oral/Sonda          Oral/Sonda\n Sabor                             Vainilla          Vainilla          Vainilla          Neutro         Neutro           Café           Neutro          Frutas Trop.       Neutro             Vainilla        Fresa, vainilla       Vainilla            Vainilla\n\n\n\n Imagen\n\n\n\n  16       miniVADEMECUM Nutricional                                                                                                                                              Equipo de Soporte Nutricional - Hospital Clínico Virgen de la Victoria         17\n---\n                   Petitorio de dietas en Nutrición Parenteral (NP).\n1.3                Composición y propiedades.\n N. PARENTERAL                                                         Dietas estandar                                                                                      Dietas estandar\n\n\n\n Tipo dietas                              Complementaria                               NPT con lipidos                                 NPT sin lípidos                                                  Periféricas\n\n\n\n Nombre                                 Nutriflex Lipid Plus            N-10          N-12          N-14          N-16           N-11                     N-13                    N-9 P                            ISOPLASMAL\n                                                  N-7\n                                                                                                                                                                               Antiflebítico:\n Especificaciones                      Sustituye a NPT lipidos               Dietas patron de mantenimiento              Se incluyen 40 g de grasa LCT una vez              2000 UI heparina          Hipocalórica. Post. Cirugia media si\n                                            en ritmo 48h                                                                        por semana desde el 8º día.                  sódica + 20 mg               desnutrición leve-mod. previa\n                                                                                                                                                                             Hidrocortisona\n Peso orient. aprox. Ideal (kg)             Inicio-retirada              50             60            70            80            55                       65                       45                        --                       --\n Nitrógeno g                                      6,8                   10,1            12            14           16,2           11                      13,1                       9                       4,7                      9,4\n                                                    Patrón estándar proteína de alto valor biológico                                                      Patrón estándar proteína de alto valor biológico\n Patrón de aminoácidos                                                Posible suplementar nutrición con Dipeptiven           Posible suplementar nutrición con\n                                                                                     (Pacientes Críticos)                     Dipeptiven (Pacientes Críticos)*\n Energía (Kcal totales)                         1.265                  1.553         1.800          2.050         2.305          1.175                   1.428                    1.425                      320                      640\n Calorías no proteicas                          1.100                  1.300         1.500          1.700         1.900          900                     1.100                    1.200                      200                      400\n Calorías no prot/gN                             161                     129           125           121           117            82                      107                      133                      69,6                     69,6\n Glucosa g                                       150                     200           250           250           300           225                      275                      125                       50                       100\n Lípidos g                                        50                     50             50            70            70             --                       --                      70                        --                       --\n (LCT 80% oliva / 20% soja)                Lípido MCT/LCT                    Sustituible por MCT/LCT soja/w3                                                      Sustituible por MCT/LCT soja/w3\n Relación Calorica HC/L (%)                     54/46                  62/38         67/33          59/41         63/37            --                       --                    42/58                       --                       --\n Sodio mEq                                        45                    50,8            65            80            80            60                      82,5                     97,6\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HOSPITAL CLÍNICO VIRGEN DE LA VICTORIA<|>ORGANIZATION<|>Hospital Clínico Virgen de la Victoria is a clinical hospital that provides nutritional support and dietary management for patients.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional Parenteral (NP) refers to the dietary management and nutritional support provided intravenously to patients who cannot consume food orally.)\n##\n(\"entity\"<|>NUTRIFLEX LIPID PLUS<|>ORGANIZATION<|>Nutriflex Lipid Plus is a nutritional product used in parenteral nutrition, designed to provide essential nutrients to patients.)\n##\n(\"entity\"<|>DIPEPTIVEN<|>ORGANIZATION<|>Dipeptiven is a nutritional supplement used to support patients in critical conditions, enhancing their nutritional intake.)\n##\n(\"relationship\"<|>HOSPITAL CLÍNICO VIRGEN DE LA VICTORIA<|>NUTRICIÓN PARENTERAL<|>The hospital provides nutritional parenteral support to patients who require dietary management<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>NUTRIFLEX LIPID PLUS<|>Nutriflex Lipid Plus is a product used in the nutritional parenteral diets<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>DIPEPTIVEN<|>Dipeptiven is a supplement that can be used to enhance nutritional support in parenteral nutrition<|>7)\n<|COMPLETE|>"}]}